Skip to content
ClinCalc Pro
Menu
Nasal decongestant — sympathomimetic (perioperative / ENT use)

Ephedrine Hydrochloride 0.5% Nasal Drops

Brand names: Ephedrine nasal drops (generic — no UK branded preparation)

Ephedrine hydrochloride nasal drops are a topical sympathomimetic decongestant used for short-term relief of nasal congestion.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Ephedrine stimulates alpha-adrenergic receptors on nasal mucosal blood vessels, causing vasoconstriction that reduces mucosal swelling and congestion.

Prescribing in practice

  • Use should be limited to a few days only, as prolonged topical decongestant use causes rebound congestion (rhinitis medicamentosa).
  • Use cautiously in patients with hypertension, hyperthyroidism, ischaemic heart disease or diabetes given the sympathomimetic effects.
  • Avoid concurrent use with monoamine oxidase inhibitors because of the risk of a hypertensive reaction.

Monitoring

No specific laboratory monitoring is needed; review if congestion persists or rebound symptoms develop after short-term use.

Counselling the patient

  • Use only for a few days at a time to avoid worsening, rebound stuffiness.
  • Do not share the dropper bottle with others to prevent cross-infection.
  • Tell the pharmacist if you take medicines for blood pressure, the heart or depression.

Evidence & guidelines

Topical decongestants give effective short-term symptomatic relief of nasal congestion but are not recommended for prolonged use, consistent with standard UK prescribing references.

Reference: RCOphth / ENT-UK Perioperative Guidelines; British Journal of Anaesthesia Nasal Decongestants; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.